As Huntington Ingalls Inds (HII) Stock Price Declined, Stevens Capital Management LP Lifted Stake; Columbus Circle Investors Lowered Its Position in Jazz Pharmaceuticals Plc (JAZZ) as Share Price Rose

February 18, 2018 - By Darrin Black

Matthew Tewksbury increased its stake in Huntington Ingalls Inds Inc (HII) by 124.62% based on its latest 2017Q3 regulatory filing with the SEC. Stevens Capital Management Lp bought 3,811 shares as the company’s stock declined 7.75% while stock markets rallied. The hedge fund run by Matthew Tewksbury held 6,869 shares of the capital goods company at the end of 2017Q3, valued at $1.56 million, up from 3,058 at the end of the previous reported quarter. Stevens Capital Management Lp who had been investing in Huntington Ingalls Inds Inc for a number of months, seems to be bullish on the $12.03B market cap company. The stock increased 4.04% or $10.31 during the last trading session, reaching $265.7. About 980,915 shares traded or 70.71% up from the average. Huntington Ingalls Industries, Inc. (NYSE:HII) has risen 26.91% since February 18, 2017 and is uptrending. It has outperformed by 10.21% the S&P500.

Donald Chiboucis decreased its stake in Jazz Pharmaceuticals Plc (JAZZ) by 36.54% based on its latest 2017Q3 regulatory filing with the SEC. Columbus Circle Investors sold 33,697 shares as the company’s stock rose 8.72% with the market. The hedge fund run by Donald Chiboucis held 58,512 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $8.56M, down from 92,209 at the end of the previous reported quarter. Columbus Circle Investors who had been investing in Jazz Pharmaceuticals Plc for a number of months, seems to be less bullish one the $8.74 billion market cap company. The stock increased 1.23% or $1.77 during the last trading session, reaching $145.76. About 294,731 shares traded. Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has risen 1.25% since February 18, 2017 and is uptrending. It has underperformed by 15.45% the S&P500.

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.14, from 0.96 in 2017Q2. It fall, as 31 investors sold HII shares while 150 reduced holdings. 41 funds opened positions while 108 raised stakes. 37.19 million shares or 3.38% less from 38.49 million shares in 2017Q2 were reported. State Of Tennessee Treasury Department holds 0.06% or 54,037 shares. Putnam Invs Ltd Com owns 0.03% invested in Huntington Ingalls Industries, Inc. (NYSE:HII) for 55,430 shares. Benjamin F Edwards & accumulated 2,481 shares or 0.07% of the stock. State Board Of Administration Of Florida Retirement System has invested 0.04% in Huntington Ingalls Industries, Inc. (NYSE:HII). Sumitomo Mitsui reported 142,841 shares. Dekabank Deutsche Girozentrale owns 5,829 shares or 0.01% of their US portfolio. Loring Wolcott & Coolidge Fiduciary Advsrs Llp Ma invested 0% of its portfolio in Huntington Ingalls Industries, Inc. (NYSE:HII). Andra Ap holds 24,000 shares. Prescott Lc has invested 0.37% in Huntington Ingalls Industries, Inc. (NYSE:HII). Oppenheimer Asset holds 0.03% of its portfolio in Huntington Ingalls Industries, Inc. (NYSE:HII) for 4,840 shares. Thompson Davis & owns 95 shares. Brandywine Global Mngmt Ltd Co holds 44,064 shares. 15,018 were reported by Fjarde Ap. Korea Investment Corporation reported 0.05% of its portfolio in Huntington Ingalls Industries, Inc. (NYSE:HII). 1,160 were accumulated by Balyasny Asset Mgmt Lc.

Stevens Capital Management Lp, which manages about $6.88B and $2.69B US Long portfolio, decreased its stake in Toronto Dominion Bk Ont (NYSE:TD) by 19,264 shares to 54,099 shares, valued at $3.04M in 2017Q3, according to the filing. It also reduced its holding in Arconic Inc by 112,616 shares in the quarter, leaving it with 35,343 shares, and cut its stake in China Mobile Limited (NYSE:CHL).

Among 9 analysts covering Huntington Ingalls Industries (NYSE:HII), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. Huntington Ingalls Industries had 33 analyst reports since August 7, 2015 according to SRatingsIntel. As per Friday, February 16, the company rating was upgraded by Credit Suisse. The firm earned “Buy” rating on Thursday, January 12 by Bank of America. Stifel Nicolaus maintained the stock with “Sell” rating in Thursday, August 3 report. The rating was initiated by Guggenheim on Wednesday, January 20 with “Buy”. Wells Fargo downgraded Huntington Ingalls Industries, Inc. (NYSE:HII) on Friday, August 5 to “Market Perform” rating. Cowen & Co upgraded Huntington Ingalls Industries, Inc. (NYSE:HII) on Friday, February 2 to “Buy” rating. Cowen & Co maintained it with “Hold” rating and $210.0 target in Tuesday, August 22 report. On Friday, June 16 the stock rating was maintained by Cowen & Co with “Hold”. On Monday, December 5 the stock rating was maintained by Deutsche Bank with “Buy”. The rating was maintained by Stifel Nicolaus on Friday, February 17 with “Sell”.

Among 21 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Jazz Pharmaceuticals had 71 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Buy” rating by SunTrust on Thursday, June 2. The firm has “Buy” rating by Cantor Fitzgerald given on Tuesday, November 7. The stock has “Neutral” rating by Mizuho on Thursday, April 6. As per Friday, September 22, the company rating was maintained by Cowen & Co. The stock of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has “Buy” rating given on Wednesday, June 7 by Cowen & Co. Mizuho maintained Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) on Tuesday, February 21 with “Buy” rating. The firm earned “Buy” rating on Tuesday, December 5 by FBR Capital. The firm has “Hold” rating by Morgan Stanley given on Thursday, October 5. Northland Capital initiated Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) rating on Wednesday, October 14. Northland Capital has “Outperform” rating and $200 target. H.C. Wainwright initiated the stock with “Hold” rating in Friday, August 25 report.

Since August 14, 2017, it had 0 insider buys, and 8 insider sales for $2.23 million activity. 9,000 shares valued at $1.26M were sold by ENRIGHT PATRICK G on Monday, December 11. 200 shares were sold by MILLER MICHAEL PATRICK, worth $28,876. The insider Treacy Paul sold 1,304 shares worth $186,884. Young Matthew P. sold $106,512 worth of stock.

Analysts await Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) to report earnings on February, 27. They expect $2.63 EPS, up 37.70% or $0.72 from last year’s $1.91 per share. JAZZ’s profit will be $157.66M for 13.86 P/E if the $2.63 EPS becomes a reality. After $2.93 actual EPS reported by Jazz Pharmaceuticals Public Limited Company for the previous quarter, Wall Street now forecasts -10.24% negative EPS growth.

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.36, from 1.39 in 2017Q2. It worsened, as 39 investors sold JAZZ shares while 82 reduced holdings. 31 funds opened positions while 94 raised stakes. 53.58 million shares or 3.54% more from 51.74 million shares in 2017Q2 were reported. Hsbc Public Llc holds 0% or 6,251 shares. Reilly Advsr Ltd Llc has 23 shares for 0% of their portfolio. Shaker Investments Limited Liability Co Oh holds 5,789 shares. Cwm Limited Co stated it has 119 shares or 0% of all its holdings. Fin owns 154 shares or 0.01% of their US portfolio. Ajo LP invested in 5,969 shares. Westpac Corp stated it has 0.01% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Citigroup Incorporated has invested 0% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). California State Teachers Retirement Sys holds 0% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) for 2,901 shares. Korea Invest holds 0.02% or 28,800 shares in its portfolio. Condor Cap Mgmt, New Jersey-based fund reported 8,778 shares. Meiji Yasuda Asset Mngmt Co Limited holds 0.05% or 3,200 shares in its portfolio. Profund Advisors Limited Liability has 3,056 shares for 0.02% of their portfolio. Eaton Vance Mngmt reported 0.05% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Prelude Capital Mgmt, New York-based fund reported 30,312 shares.

Columbus Circle Investors, which manages about $17.54 billion and $5.87 billion US Long portfolio, upped its stake in Central Garden & Pet Co (NASDAQ:CENTA) by 19,419 shares to 96,322 shares, valued at $3.58M in 2017Q3, according to the filing. It also increased its holding in Splunk Inc (NASDAQ:SPLK) by 40,388 shares in the quarter, for a total of 57,838 shares, and has risen its stake in Ii Vi Inc (NASDAQ:IIVI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts